• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢因素与代谢综合征与癌症项目(Me-Can)中 58 万男性和女性的结直肠癌风险。

Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can).

机构信息

Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden; Institute of Health Sciences, Free University, Amsterdam, The Netherlands.

出版信息

Cancer. 2011 Jun 1;117(11):2398-407. doi: 10.1002/cncr.25772. Epub 2010 Dec 17.

DOI:10.1002/cncr.25772
PMID:24048787
Abstract

BACKGROUND

The metabolic syndrome (MetS) has been related to an increased risk of colorectal cancer, but the modest size of previous studies precluded detailed characterization of the role of individual MetS factors and their interaction on risk.

METHODS

In the Metabolic Syndrome and Cancer Project (Me-Can), data on body mass index (BMI), blood pressure, and blood levels of glucose, cholesterol, and triglycerides were available for 578,700 men and women. The mean age of participants at baseline was 44 years, and the mean follow-up was 12 years. Relative risks (RR) of colorectal cancer per 1 standard deviation increment in Z score of factors and for a combined MetS score, were calculated from Cox regression models, including adjustment for potential confounders.

RESULTS

During follow-up, 2834 men and 1861 women were diagnosed with colorectal cancer. The RR of colorectal cancer for the MetS score was 1.25 (95% confidence interval [CI], 1.18-1.32) in men, and 1.14 (95% CI, 1.06-1.22) in women. Significant associations also were observed in men for BMI (RR, 1.07; 95% CI, 1.02-1.13), blood pressure (RR, 1.10; 95% CI, 1.02-1.18), and triglycerides (RR, 1.17; 95% CI, 1.06-1.28) and, in women, for BMI (RR, 1.08; 95% CI, 1.01-1.15). There was no significant positive interaction between the metabolic factors on risk.

CONCLUSIONS

The combination of metabolic factors and some separate factors was related to an increased risk of colorectal cancer, but there was no interaction between metabolic factors.

摘要

背景

代谢综合征(MetS)与结直肠癌风险增加相关,但先前研究的规模较小,无法详细描述单个 MetS 因素及其相互作用对风险的作用。

方法

在代谢综合征和癌症项目(Me-Can)中,有 578700 名男性和女性的体重指数(BMI)、血压以及血糖、胆固醇和甘油三酯的血液水平数据可用。参与者的基线年龄平均为 44 岁,平均随访时间为 12 年。使用 Cox 回归模型,包括对潜在混杂因素的调整,计算出每个因素 Z 分数的标准偏差增量和综合 MetS 评分的结直肠癌风险相对风险(RR)。

结果

在随访期间,2834 名男性和 1861 名女性被诊断患有结直肠癌。男性的 MetS 评分的结直肠癌 RR 为 1.25(95%置信区间 [CI],1.18-1.32),女性为 1.14(95% CI,1.06-1.22)。在男性中,BMI(RR,1.07;95% CI,1.02-1.13)、血压(RR,1.10;95% CI,1.02-1.18)和甘油三酯(RR,1.17;95% CI,1.06-1.28)也存在显著关联,在女性中,BMI(RR,1.08;95% CI,1.01-1.15)也存在显著关联。代谢因素之间的风险没有显著的正交互作用。

结论

代谢因素的组合和一些单独的因素与结直肠癌风险增加有关,但代谢因素之间没有相互作用。

相似文献

1
Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can).代谢因素与代谢综合征与癌症项目(Me-Can)中 58 万男性和女性的结直肠癌风险。
Cancer. 2011 Jun 1;117(11):2398-407. doi: 10.1002/cncr.25772. Epub 2010 Dec 17.
2
Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.代谢综合征与癌症项目中的代谢风险因素与卵巢癌。
Int J Epidemiol. 2011 Dec;40(6):1667-77. doi: 10.1093/ije/dyr130. Epub 2011 Oct 7.
3
Prospective study on metabolic factors and risk of prostate cancer.前瞻性研究代谢因素与前列腺癌风险。
Cancer. 2012 Dec 15;118(24):6199-206. doi: 10.1002/cncr.27677. Epub 2012 Oct 22.
4
Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.代谢综合征与美加(代谢综合征与癌症)项目中的乳腺癌。
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1737-45. doi: 10.1158/1055-9965.EPI-10-0230.
5
Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).代谢综合征与癌症项目(Me-Can)中的代谢风险因素与皮肤癌。
Br J Dermatol. 2012 Jul;167(1):59-67. doi: 10.1111/j.1365-2133.2012.10974.x. Epub 2012 Apr 24.
6
Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).代谢综合征与膀胱癌风险:代谢综合征与癌症项目(Me-Can)的前瞻性队列研究。
Int J Cancer. 2011 Apr 15;128(8):1890-8. doi: 10.1002/ijc.25521.
7
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).代谢综合征与癌症项目(Me-Can)中的代谢风险因素与宫颈癌。
Gynecol Oncol. 2012 May;125(2):330-5. doi: 10.1016/j.ygyno.2012.01.052. Epub 2012 Feb 10.
8
Colorectal cancer mortality and factors related to the insulin resistance syndrome.结直肠癌死亡率与胰岛素抵抗综合征相关因素
Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):385-91.
9
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.代谢风险因素与 578700 名成年人原发性肝癌的前瞻性研究。
Int J Cancer. 2012 Jul 1;131(1):193-200. doi: 10.1002/ijc.26338. Epub 2011 Sep 8.
10
Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).代谢综合征与癌症项目(Me-Can)中代谢风险因素与胃腺癌风险的前瞻性队列研究。
Cancer Causes Control. 2013 Jan;24(1):107-16. doi: 10.1007/s10552-012-0096-6. Epub 2012 Nov 13.

引用本文的文献

1
The role and mechanism of abnormal lipid metabolism in colorectal cancer.异常脂质代谢在结直肠癌中的作用及机制
Sci Prog. 2025 Jul-Sep;108(3):368504251368237. doi: 10.1177/00368504251368237. Epub 2025 Sep 10.
2
Association of triglyceride-glucose related indices with colorectal cancer risk among the US population: a cross-sectional study.美国人群中甘油三酯-葡萄糖相关指标与结直肠癌风险的关联:一项横断面研究。
BMC Cancer. 2025 Jul 18;25(1):1186. doi: 10.1186/s12885-025-14625-8.
3
The Influence of Metabolic Syndrome on the Development of Gastrointestinal Malignant Tumors-A Review.
代谢综合征对胃肠道恶性肿瘤发生发展的影响——综述
Medicina (Kaunas). 2025 May 31;61(6):1025. doi: 10.3390/medicina61061025.
4
Associations of combined lifestyle and metabolic risks with cancer incidence in the UK biobank study.英国生物银行研究中综合生活方式和代谢风险与癌症发病率的关联。
BMC Cancer. 2025 Mar 26;25(1):547. doi: 10.1186/s12885-025-13955-x.
5
Global burden of colorectal cancer attributable to metabolic risks from 1990 to 2021, with predictions to 2046.1990年至2021年因代谢风险导致的全球结直肠癌负担,并预测至2046年。
BMC Cancer. 2025 Feb 10;25(1):228. doi: 10.1186/s12885-025-13643-w.
6
Serum Lipid Biomarkers and the Risk of Gastrointestinal Cancers in a Chinese Population: The Kailuan Prospective Study.血清脂质生物标志物与中国人群胃肠道癌症风险:开滦前瞻性研究
Cancer Med. 2025 Feb;14(3):e70654. doi: 10.1002/cam4.70654.
7
Risk of Colorectal Cancer among Patients with One or Multiple Metabolic Syndrome Components.患有一种或多种代谢综合征成分的患者患结直肠癌的风险。
Cancers (Basel). 2024 Sep 30;16(19):3350. doi: 10.3390/cancers16193350.
8
Obesity and Colorectal Cancer: A Narrative Review.肥胖与结直肠癌:一篇叙述性综述。
Medicina (Kaunas). 2024 Jul 27;60(8):1218. doi: 10.3390/medicina60081218.
9
Genetic prediction of the relationship between metabolic syndrome and colorectal cancer risk: a Mendelian randomization study.代谢综合征与结直肠癌风险关系的遗传预测:一项孟德尔随机化研究
Diabetol Metab Syndr. 2024 May 22;16(1):109. doi: 10.1186/s13098-024-01351-7.
10
The Relationship Between Serum Lipids and the Formation of Colorectal Polyps.血清脂质与大肠息肉形成之间的关系
Cureus. 2024 Apr 3;16(4):e57511. doi: 10.7759/cureus.57511. eCollection 2024 Apr.